'Moonshot' Opportunities: Dx Reimbursement, Radiation Therapy Among Medtech Focal Points

Personalized-medicine advocates say Vice President Biden's "Cancer Moonshot" initiative is a great opportunity, but it should be putting more focus on the importance of Medicare policies in driving cancer innovation. There is also a push in the medtech space to raise the profile of radiation therapy as a central tool for treating cancer.

More from Regulation

More from Policy & Regulation